INM logo

InMed Pharmaceuticals (INM) Cash From Investing

Annual CFI

-$9300.00
+$652.50 K+98.59%

June 30, 2024

Summary

Performance

1-Year Change

+98.59%

3-Year Change

-447.06%

5-Year Change

+99.56%

15-Year Change

+52.31%

INM Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.95%
INM annual cash flow from investing activities is higher than 62.95% of companies in Healthcare sector

High & Low

All-time High

$3.79 M
INM annual cash flow from investing activities is currently -100.25% below its historical high of $3.79 million

3-Year Low

-$673.00 K

Earnings dates

Last Annual Earnings Report Date

Jun 30, 2024
INM previous annual earnings announcement was published on Jun 30, 2024

Next Annual Earnings Report Date

N/A
INM next annual earnings announcement has not yet been scheduled

OtherINMcash flowmetrics:

Annual CFF

$4.65 M
INM annual cash flow from financing activities is $4.65 million

Annual CFO

-$6.99 M
INM annual cash flow from operations is -$6.99 million

Annual FCF

-$7.00 M
INM annual free cash flow is -$7.00 million

Annual CAPEX

$9300.00
INM annual capital expenditures is $9300.00

Quarterly CFI

$0.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

0%

3-Year Change

+100%

5-Year Change

0%

INM Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

68.16%
INM quarterly cash flow from investing activities is higher than 68.16% of companies in Healthcare sector

High & Low

All-time High

$3.74 M
INM quarterly cash flow from investing activities is currently -100.00% below its historical high of $3.74 million

3-Year Low

-$725.50 K

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
INM next earnings announcement is scheduled for Feb 13, 2025

OtherINMcash flowmetrics:

Quarterly CFF

$838.20 K
INM quarterly cash flow from financing activities is $838.20 thousand

Quarterly CFO

-$1.83 M
INM quarterly cash flow from operations is -$1.83 million

Quarterly FCF

-$1.83 M
INM quarterly free cash flow is -$1.83 million

Quarterly CAPEX

-
INM quarterly capital expenditures value is unknown

TTM CFI

-$9300.00
$0.000.00%

September 30, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+78.32%

3-Year Change

+98.62%

5-Year Change

-17.72%

INM TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

62.4%
INM TTM cash flow from investing activities is higher than 62.4% of companies in Healthcare sector

High & Low

All-time High

$5.53 M
INM TTM cash flow from investing activities is currently -100.17% below its historical high of $5.53 million

3-Year Low

-$1.35 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
INM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 13, 2025
INM next earnings announcement is scheduled for Feb 13, 2025

OtherINMcash flowmetrics:

TTM CFF

$5.49 M
INM TTM cash flow from financing activities is $5.49 million

TTM CFO

-$6.64 M
INM TTM cash flow from operations is -$6.64 million

TTM FCF

-$6.65 M
INM TTM free cash flow is -$6.65 million

TTM CAPEX

-
INM TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

INM Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+98.6%0.0%+78.3%
3 y3 years-447.1%+100.0%+98.6%
5 y5 years+99.6%0.0%-17.7%

INM Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-447.1%+98.6%-100.0%+100.0%-117.1%+99.3%
5 y5-year-100.3%+99.6%-100.0%+100.0%-100.2%+99.3%
alltimeall time-100.3%+99.6%-100.0%+100.0%-100.2%+99.8%

InMed Pharmaceuticals Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$0.00(0.0%)
-$9300.00(0.0%)
Jun 2024
-$9300.00(-98.6%)
$0.00(0.0%)
-$9300.00(-78.3%)
Mar 2024
-
$0.00(-100.0%)
-$42.90 K(-74.9%)
Dec 2023
-
-$9300.00(<-9900.0%)
-$171.10 K(-74.1%)
Sep 2023
-
$0.00(-100.0%)
-$661.80 K(0.0%)
Jun 2023
-$661.80 K(-1.7%)
-$33.60 K(-73.8%)
-$661.80 K(-51.1%)
Mar 2023
-
-$128.20 K(-74.4%)
-$1.35 M(+10.1%)
Dec 2022
-
-$500.00 K(<-9900.0%)
-$1.23 M(+190.5%)
Sep 2022
-
$0.00(-100.0%)
-$423.10 K(-37.1%)
Jun 2022
-$673.00 K(>+9900.0%)
-$725.50 K(>+9900.0%)
-$673.10 K(-1427.6%)
Mar 2022
-
-$3600.00(-101.2%)
$50.70 K(-6.6%)
Dec 2021
-
$306.00 K(-222.4%)
$54.30 K(-121.6%)
Sep 2021
-
-$250.00 K(>+9900.0%)
-$251.70 K(>+9900.0%)
Jun 2021
-$1700.00(-100.0%)
-$1700.00(<-9900.0%)
-$1700.00(-288.9%)
Mar 2021
-
$0.00(0.0%)
$900.00(-111.4%)
Dec 2020
-
$0.00(0.0%)
-$7900.00(-116.8%)
Sep 2020
-
$0.00(-100.0%)
$47.00 K(-98.8%)
Jun 2020
$3.79 M(-280.0%)
$900.00(-110.2%)
$3.79 M(-30.6%)
Mar 2020
-
-$8800.00(-116.0%)
$5.46 M(+1.3%)
Dec 2019
-
$54.90 K(-98.5%)
$5.39 M(-2.5%)
Sep 2019
-
$3.74 M(+123.6%)
$5.53 M(-362.7%)
Jun 2019
-$2.11 M(+16.1%)
$1.67 M(-2243.4%)
-$2.11 M(-43.8%)
Mar 2019
-
-$78.10 K(-140.5%)
-$3.75 M(-31.7%)
Dec 2018
-
$192.90 K(-105.0%)
-$5.48 M(-3.9%)
Sep 2018
-
-$3.89 M(<-9900.0%)
-$5.70 M(+214.6%)
Jun 2018
-$1.81 M(+9196.9%)
$33.40 K(-101.8%)
-$1.81 M(-2.2%)
Mar 2018
-
-$1.81 M(+6266.0%)
-$1.85 M(+3487.2%)
Dec 2017
-
-$28.50 K(+691.7%)
-$51.70 K(+122.8%)
Sep 2017
-
-$3600.00(-56.1%)
-$23.20 K(+18.4%)
Jun 2017
-$19.50 K(+2066.7%)
-$8200.00(-28.1%)
-$19.60 K(-225.6%)
Mar 2017
-
-$11.40 K(<-9900.0%)
$15.60 K(>+9900.0%)
Dec 2016
-
$0.00(0.0%)
$0.00(0.0%)
Sep 2016
-
$0.00(-100.0%)
$0.00(-100.0%)
Jun 2016
-$900.00(-81.3%)
$27.00 K(-200.0%)
-$900.00(-96.8%)
Mar 2016
-
-$27.00 K(<-9900.0%)
-$28.00 K(+4566.7%)
Dec 2015
-
$0.00(-100.0%)
-$600.00(-89.7%)
Sep 2015
-
-$900.00(+800.0%)
-$5800.00(+18.4%)
Jun 2015
-$4800.00
-$100.00(-125.0%)
-$4900.00(-27.9%)
DateAnnualQuarterlyTTM
Mar 2015
-
$400.00(-107.7%)
-$6800.00(-5.6%)
Dec 2014
-
-$5200.00(<-9900.0%)
-$7200.00(+260.0%)
Sep 2014
-
$0.00(-100.0%)
-$2000.00(0.0%)
Jun 2014
-$2000.00(<-9900.0%)
-$2000.00(<-9900.0%)
-$2000.00(<-9900.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2013
$0.00(0.0%)
-
-
Sep 2011
-
$0.00(0.0%)
$0.00(-100.0%)
Jun 2011
$0.00(-100.0%)
-
-
Sep 2008
-
$0.00(-100.0%)
$249.30 K(+4.7%)
Jun 2008
$238.10 K(-2389.4%)
$377.60 K(-28.3%)
$238.10 K(-258.8%)
Mar 2008
-
$526.70 K(-180.4%)
-$149.90 K(-77.0%)
Dec 2007
-
-$655.00 K(+5748.2%)
-$650.50 K(<-9900.0%)
Sep 2007
-
-$11.20 K(+7.7%)
$5600.00(-153.3%)
Jun 2007
-$10.40 K(<-9900.0%)
-$10.40 K(-139.8%)
-$10.50 K(-115.2%)
Mar 2007
-
$26.10 K(+2272.7%)
$69.10 K(+59.6%)
Dec 2006
-
$1100.00(-104.0%)
$43.30 K(+144.6%)
Sep 2006
-
-$27.30 K(-139.5%)
$17.70 K(>+9900.0%)
Jun 2006
$0.00(-100.0%)
$69.20 K(>+9900.0%)
$0.00(-100.0%)
Mar 2006
-
$300.00(-101.2%)
$1.12 M(-0.7%)
Dec 2005
-
-$24.50 K(-45.6%)
$1.12 M(-370.0%)
Sep 2005
-
-$45.00 K(-103.8%)
-$415.80 K(+11.9%)
Jun 2005
-$371.60 K(-2119.6%)
$1.18 M(>+9900.0%)
-$371.70 K(-76.2%)
Mar 2005
-
$7800.00(-100.5%)
-$1.56 M(-0.6%)
Dec 2004
-
-$1.56 M(>+9900.0%)
-$1.57 M(>+9900.0%)
Sep 2004
-
-$900.00(-75.7%)
-$9300.00(-150.8%)
Jul 2004
$18.40 K(-94.2%)
-$3700.00(+131.3%)
$18.30 K(-108.1%)
Apr 2004
-
-$1600.00(-48.4%)
-$225.50 K(+694.0%)
Jan 2004
-
-$3100.00(-111.6%)
-$28.40 K(-121.5%)
Oct 2003
-
$26.70 K(-110.8%)
$131.80 K(-58.4%)
Jul 2003
$316.70 K(-71.4%)
-$247.50 K(-226.6%)
$316.70 K(-54.7%)
Apr 2003
-
$195.50 K(+24.4%)
$698.40 K(-15.3%)
Jan 2003
-
$157.10 K(-25.8%)
$824.30 K(-14.0%)
Oct 2002
-
$211.60 K(+57.7%)
$958.70 K(-13.4%)
Jul 2002
$1.11 M(-161.3%)
$134.20 K(-58.2%)
$1.11 M(+13.8%)
Apr 2002
-
$321.40 K(+10.3%)
$973.20 K(+49.3%)
Jan 2002
-
$291.50 K(-19.1%)
$651.80 K(+80.9%)
Oct 2001
-
$360.30 K
$360.30 K
Jul 2001
-$1.81 M
-
-

FAQ

  • What is InMed Pharmaceuticals annual cash flow from investing activities?
  • What is the all time high annual CFI for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals annual CFI year-on-year change?
  • What is InMed Pharmaceuticals quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals quarterly CFI year-on-year change?
  • What is InMed Pharmaceuticals TTM cash flow from investing activities?
  • What is the all time high TTM CFI for InMed Pharmaceuticals?
  • What is InMed Pharmaceuticals TTM CFI year-on-year change?

What is InMed Pharmaceuticals annual cash flow from investing activities?

The current annual CFI of INM is -$9300.00

What is the all time high annual CFI for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high annual cash flow from investing activities is $3.79 M

What is InMed Pharmaceuticals annual CFI year-on-year change?

Over the past year, INM annual cash flow from investing activities has changed by +$652.50 K (+98.59%)

What is InMed Pharmaceuticals quarterly cash flow from investing activities?

The current quarterly CFI of INM is $0.00

What is the all time high quarterly CFI for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high quarterly cash flow from investing activities is $3.74 M

What is InMed Pharmaceuticals quarterly CFI year-on-year change?

Over the past year, INM quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is InMed Pharmaceuticals TTM cash flow from investing activities?

The current TTM CFI of INM is -$9300.00

What is the all time high TTM CFI for InMed Pharmaceuticals?

InMed Pharmaceuticals all-time high TTM cash flow from investing activities is $5.53 M

What is InMed Pharmaceuticals TTM CFI year-on-year change?

Over the past year, INM TTM cash flow from investing activities has changed by +$33.60 K (+78.32%)